Indications
Therapeutic Asset Ratings
5,099 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rifaximin
Small Intestinal Bacterial Overgrowth
I.M. Sechenov First Moscow State Medical University
P3
B
(62)
Rituximab
Acute Myeloid Leukemia
Prelude Therapeutics
P3
B
(62)
Rituximab
B-Cell Acute Lymphoblastic Leukemia
University of Washington
P3
B
(62)
Rituximab
Large B-Cell Lymphoma
Ruijin Hospital
P3
B
(62)
Rituximab
Relapsing-Remitting Multiple Sclerosis
University Hospital, Montpellier
P3
B
(62)
Rituximab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
P3
B
(62)
Romiplostim
Thrombocytopenia
Ain Shams University
P3
B
(62)
Ruxolitinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Center for International Blood and Marrow Transplant Research
P3
B
(62)
Sacubitrilat
Hypertensive Disorder
Novartis Pharmaceuticals
P3
B
(62)
Serplulimab
Rectal Carcinoma
Fudan University
P3
B
(62)
Siltuximab
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
P3
B
(62)
Siponimod
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals
P3
B
(62)
Sirolimus
B-Cell Chronic Lymphocytic Leukemia
Masonic Cancer Center, University of Minnesota
P3
B
(62)
Sirolimus
Waldenstrom Macroglobulinemia
Fred Hutchinson Cancer Center
P3
B
(62)
Solanezumab
Alzheimer Disease
Eli Lilly and Company
P3
B
(62)
Sorafenib
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
The First Affiliated Hospital of Soochow University
P3
B
(62)
Surovatamig
Large B-Cell Lymphoma
AstraZeneca
P3
B
(62)
Surufatinib
Neuroendocrine Neoplasm
Shanghai Changzheng Hospital
P3
B
(62)
Syhx2011
Breast Cancer
CSPC Ouyi Pharmaceutical Co., Ltd.
P3
B
(62)
Tacrolimus
Acute Leukemia
Masonic Cancer Center, University of Minnesota
P3
B
(62)
Tacrolimus
Plasma Cell Neoplasm
Dartmouth-Hitchcock Medical Center
P3
B
(62)
Tazemetostat
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Fudan University
P3
B
(62)
Testosterone Undecylate
Cancer
Aminex Therapeutics, Inc.
P3
B
(62)
tg103
Obesity Disorder
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
P3
B
(62)
Thioguanine Anhydrous
B-Cell Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
P3
B
(62)
Showing 1926 to 1950 of 5,099 assets
Previous
Page 78 of 204
Next